Reform of pharma legislation: the debate on regulatory data protection
by Giuliana Miglierini As the definition of the final contents of many new pieces of the overall revision…
EMA’s pilot scheme for academic and non-profit development of ATMPs
by Giuliana Miglierini Advanced therapy medicinal products (ATMPs) are often developed by academic and non-profit organisations, because of…
The EU Commission proposal of the new pharmaceutical legislation
By Giuliana Miglierini After a five-months delay, the European Commission has announced on 26 April 2023 its proposal…
Consultation on the reform of the European pharmaceutical legislation
by Giuliana Miglierini A new step in the review of the overall framework governing the pharmaceutical sector has…